← Evidence map

ArticleAmerican journal of translational research2023

High expression of KMT2D is a promising biomarker for poor gastric cancer prognosis.

Tianjiao Yi et al.PubMed ↗Full text ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37056814